BioCryst Makes A Small Recovery Following Last Year’s Bad News
Posted on January 16, 2013 at 00:28 AM EST
After a string of bad news that dropped BioCryst Pharmaceuticals (NASDAQ: BCRX) by over 60% last year, we see that the stock is having trouble gaining any serious traction from buyers.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here